Literature DB >> 14610007

Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation.

Peter Razeghi1, Saumya Sharma, Jun Ying, Yi-Ping Li, Stanislaw Stepkowski, Michael B Reid, Heinrich Taegtmeyer.   

Abstract

BACKGROUND: Mechanical unloading of the heart results in atrophic remodeling. In skeletal muscle, atrophy is associated with inactivation of the mammalian target of rapamycin (mTOR) pathway and upregulation of critical components of the ubiquitin proteosome proteolytic (UPP) pathway. The hypothesis is that mechanical unloading of the mammalian heart has differential effects on pathways of protein synthesis and degradation. METHODS AND
RESULTS: In a model of atrophic remodeling induced by heterotopic transplantation of the rat heart, we measured gene transcription, protein expression, polyubiquitin content, and regulators of the mTOR pathway at 2, 4, 7, and 28 days. In atrophic hearts, there was an increase in polyubiquitin content that peaked at 7 days and decreased by 28 days. Furthermore, gene and protein expression of UbcH2, a ubiquitin conjugating enzyme, was also increased early in the course of unloading. Transcript levels of TNF-alpha, a known regulator of UbcH2-dependent ubiquitin conjugating activity, were upregulated early and transiently in the atrophying rat heart. Unexpectedly, p70S6K and 4EBP1, downstream components of mTOR, were activated in atrophic rat heart. This activation was independent of Akt, a known upstream regulator of mTOR. Rapamycin treatment of the unloaded rat hearts inhibited the activation of p70S6K and 4EBP1 and subsequently augmented atrophy in these hearts compared with vehicle-treated, unloaded hearts.
CONCLUSIONS: Atrophy of the heart, secondary to mechanical unloading, is associated with early activation of the UPP. The simultaneous activation of the mTOR pathway suggests active remodeling, involving both protein synthesis and degradation.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 14610007     DOI: 10.1161/01.CIR.0000096481.45105.13

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

1.  Myocardial remodelling in left ventricular atrophy induced by caloric restriction.

Authors:  Carina Gruber; Nadine Nink; Sandeep Nikam; Gerd Magdowski; Gerhard Kripp; Robert Voswinckel; Christian Mühlfeld
Journal:  J Anat       Date:  2011-11-13       Impact factor: 2.610

2.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

Review 3.  Proteostasis and REDOX state in the heart.

Authors:  Elisabeth S Christians; Ivor J Benjamin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

4.  Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.

Authors:  Nir Uriel; Yoshifumi Naka; Paolo C Colombo; Maryjane Farr; Sang-Woo Pak; Vlad Cotarlan; Jeanine B Albu; Dympna Gallagher; Donna Mancini; Henry N Ginsberg; Ulrich P Jorde
Journal:  Eur J Heart Fail       Date:  2010-11-23       Impact factor: 15.534

5.  Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.

Authors:  Peter Razeghi; Mou-Er Wang; Keith A Youker; Leonard Golfman; Stanislaw Stepkowski; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2007-01-03       Impact factor: 10.787

6.  Myocardial lipid accumulation and lipotoxicity in heart failure.

Authors:  P Christian Schulze
Journal:  J Lipid Res       Date:  2009-08-17       Impact factor: 5.922

Review 7.  Taking pressure off the heart: the ins and outs of atrophic remodelling.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2011-02-25       Impact factor: 10.787

8.  c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia.

Authors:  Khadija Rafiq; Mikhail A Kolpakov; Rachid Seqqat; Jianfen Guo; Xinji Guo; Zhao Qi; Daohai Yu; Bhopal Mohapatra; Neha Zutshi; Wei An; Hamid Band; Archana Sanjay; Steven R Houser; Abdelkarim Sabri
Journal:  Circulation       Date:  2014-02-28       Impact factor: 29.690

9.  Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery.

Authors:  Joshua G Leichman; Erik B Wilson; Terry Scarborough; David Aguilar; Charles C Miller; Sherman Yu; Mohamed F Algahim; Manuel Reyes; Frank G Moody; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

10.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.